Results 161 to 170 of about 3,405 (181)

Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults

New England Journal of Medicine, 2018
Dick Menzies, Mênonli Adjobimey, Anete Trajman   +2 more
exaly  

Priorities for the Treatment of Latent Tuberculosis Infection in the United States

New England Journal of Medicine, 2004
C Robert Horsburgh
exaly  

The Prevalence of Latent Tuberculosis Infection in the United States

American Journal of Respiratory and Critical Care Medicine, 2016
James D Mancuso, David J Horne, Tzu-Cheg Kao   +2 more
exaly  

LATENT TUBERCULOSIS

Medical Journal of Australia, 1920
openaire   +1 more source

The Scope and Impact of Treatment of Latent Tuberculosis Infection in the United States and Canada

American Journal of Respiratory and Critical Care Medicine, 2006
Timothy R Sterling, James Bethel, C Robert Horsburgh   +2 more
exaly  

Use of Isoniazid for Latent Tuberculosis Infection in a Public Health Clinic

American Journal of Respiratory and Critical Care Medicine, 2003
Philip A Lobue
exaly  

Latent Tuberculosis Infection in the United States

New England Journal of Medicine, 2011
C Robert Horsburgh, Eric J Rubin, Rubin Eric J   +2 more
exaly  

Latent Tuberculosis

BMJ, 1936
openaire   +1 more source

Priorities for Screening and Treatment of Latent Tuberculosis Infection in the United States

American Journal of Respiratory and Critical Care Medicine, 2011
Benjamin P Linas, Kenneth A Freedberg, C Robert Horsburgh   +2 more
exaly  

The spectrum of latent tuberculosis: rethinking the biology and intervention strategies

Nature Reviews Microbiology, 2009
Clifton E Barry, Helena I Boshoff, Véronique Dartois   +2 more
exaly